Myeloproliferative neoplasms

Morphology and clinical practice

Tiziano Barbui, Jürgen Thiele, Alessandro M. Vannucchi, Ayalew Tefferi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducibility of bone marrow (BM) features. Disagreements concerning the WHO classification are mainly focused on the discrimination between essential thrombocythemia (ET) and prefibrotic/early primary myelofibrosis (prePMF) and prodromal polycythemia vera (PV). Criticism mostly refers to lack of standardization of distinctive BM features precluding correct morphological pattern recognition. The distinction between WHO-defined ET and prePMF is not trivial because outcome is significantly worse in prePMF. Morphology was generally considered to be non-specific for the diagnosis of PV. Recent studies have revealed under-diagnosis of morphologically and biologically consistent PV. Am. J. Hematol. 91:430-433, 2016.

Original languageEnglish (US)
Pages (from-to)430-433
Number of pages4
JournalAmerican Journal of Hematology
Volume91
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Polycythemia Vera
Primary Myelofibrosis
Essential Thrombocythemia
Bone Marrow
Neoplasms

ASJC Scopus subject areas

  • Hematology

Cite this

Myeloproliferative neoplasms : Morphology and clinical practice. / Barbui, Tiziano; Thiele, Jürgen; Vannucchi, Alessandro M.; Tefferi, Ayalew.

In: American Journal of Hematology, Vol. 91, No. 4, 01.04.2016, p. 430-433.

Research output: Contribution to journalArticle

Barbui, Tiziano ; Thiele, Jürgen ; Vannucchi, Alessandro M. ; Tefferi, Ayalew. / Myeloproliferative neoplasms : Morphology and clinical practice. In: American Journal of Hematology. 2016 ; Vol. 91, No. 4. pp. 430-433.
@article{efa63bf0c5f7460e89fc26f0463c12ac,
title = "Myeloproliferative neoplasms: Morphology and clinical practice",
abstract = "In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducibility of bone marrow (BM) features. Disagreements concerning the WHO classification are mainly focused on the discrimination between essential thrombocythemia (ET) and prefibrotic/early primary myelofibrosis (prePMF) and prodromal polycythemia vera (PV). Criticism mostly refers to lack of standardization of distinctive BM features precluding correct morphological pattern recognition. The distinction between WHO-defined ET and prePMF is not trivial because outcome is significantly worse in prePMF. Morphology was generally considered to be non-specific for the diagnosis of PV. Recent studies have revealed under-diagnosis of morphologically and biologically consistent PV. Am. J. Hematol. 91:430-433, 2016.",
author = "Tiziano Barbui and J{\"u}rgen Thiele and Vannucchi, {Alessandro M.} and Ayalew Tefferi",
year = "2016",
month = "4",
day = "1",
doi = "10.1002/ajh.24288",
language = "English (US)",
volume = "91",
pages = "430--433",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Myeloproliferative neoplasms

T2 - Morphology and clinical practice

AU - Barbui, Tiziano

AU - Thiele, Jürgen

AU - Vannucchi, Alessandro M.

AU - Tefferi, Ayalew

PY - 2016/4/1

Y1 - 2016/4/1

N2 - In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducibility of bone marrow (BM) features. Disagreements concerning the WHO classification are mainly focused on the discrimination between essential thrombocythemia (ET) and prefibrotic/early primary myelofibrosis (prePMF) and prodromal polycythemia vera (PV). Criticism mostly refers to lack of standardization of distinctive BM features precluding correct morphological pattern recognition. The distinction between WHO-defined ET and prePMF is not trivial because outcome is significantly worse in prePMF. Morphology was generally considered to be non-specific for the diagnosis of PV. Recent studies have revealed under-diagnosis of morphologically and biologically consistent PV. Am. J. Hematol. 91:430-433, 2016.

AB - In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducibility of bone marrow (BM) features. Disagreements concerning the WHO classification are mainly focused on the discrimination between essential thrombocythemia (ET) and prefibrotic/early primary myelofibrosis (prePMF) and prodromal polycythemia vera (PV). Criticism mostly refers to lack of standardization of distinctive BM features precluding correct morphological pattern recognition. The distinction between WHO-defined ET and prePMF is not trivial because outcome is significantly worse in prePMF. Morphology was generally considered to be non-specific for the diagnosis of PV. Recent studies have revealed under-diagnosis of morphologically and biologically consistent PV. Am. J. Hematol. 91:430-433, 2016.

UR - http://www.scopus.com/inward/record.url?scp=84961262640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961262640&partnerID=8YFLogxK

U2 - 10.1002/ajh.24288

DO - 10.1002/ajh.24288

M3 - Article

VL - 91

SP - 430

EP - 433

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 4

ER -